Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
novalarpharm.com

See what CB Insights has to offer

Founded Year

2000

Stage

Unattributed VC | Alive

Total Raised

$58.51M

Last Raised

$1M | 11 yrs ago

About Novalar Pharmaceuticals

Novalar Pharmaceuticals develops a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures, thereby allowing patients to return to their daily activities without the speech impediments, lip biting, and difficulty in eating that can be caused by unintended soft-tissue anesthesia.

Novalar Pharmaceuticals Headquarter Location

12555 High Bluff Drive Suite 300

San Diego, California, 92130,

United States

858-436-1100

Latest Novalar Pharmaceuticals News

Novalar Pharmaceuticals Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 29, 2016

Novalar Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 23:14 EST 28 Nov 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Novalar Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Novalar Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Novalar Pharmaceuticals, Inc. since January 2007. Key Findings Provides intelligence on Novalar Pharmaceuticals, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Novalar Pharmaceuticals, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Novalar Pharmaceuticals, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Novalar Pharmaceuticals, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Novalar Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novalar Pharmaceuticals is included in 2 Expert Collections, including Dental Health.

D

Dental Health

957 items

Companies delivering dental care products and services. Excludes practice networks.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Novalar Pharmaceuticals Patents

Novalar Pharmaceuticals has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/18/2005

8/18/2009

Beta blockers, General anesthetics, Imidazolines, Phenols, Anesthesia

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/18/2005

00/00/0000

Grant Date

8/18/2009

00/00/0000

Title

Subscribe to see more

Related Topics

Beta blockers, General anesthetics, Imidazolines, Phenols, Anesthesia

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.